Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Orbicular Pharmaceutical Technologies is a specialty pharmaceutical research and development company based in Hyderabad, India, that focuses on developing complex generics and value-added medicines. The company specializes in high-barrier-to-entry dosage forms, including ophthalmic emulsions, complex injectables, and specialized topical delivery systems. Orbicular operates primarily through a B2B model, partnering with global pharmaceutical companies to license its developed formulations for commercialization in regulated markets like the United States and Europe. Their expertise spans the entire development lifecycle, from pre-formulation and analytical method development to navigating complex regulatory pathways for Abbreviated New Drug Applications (ANDAs). By targeting niche and difficult-to-replicate drug delivery technologies, Orbicular provides cost-effective alternatives for complex therapeutic products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Orbicular Pharmaceuticals.